Jason Griffin New is Director of 180 Life Sciences Corp.. Currently has a direct ownership of 492,250 shares of ATNF, which is worth approximately $1.19 Million. The most recent transaction as insider was on Nov 14, 2025, when has been sold 218,456 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 492K
n/a 3M change
n/a 12M change
Total Value Held $1.19 Million

Jason Griffin New Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 14 2025
SELL
Bona fide gift
-
218,456 Reduced 30.74%
492,250 Common Stock
Nov 12 2025
SELL
Payment of exercise price or tax liability
-
257,794 Reduced 26.6%
711,424 Common Stock
Nov 12 2025
BUY
Grant, award, or other acquisition
-
952,500 Added 50.0%
952,500 Common Stock

Also insider at

KODK
EASTMAN KODAK CO Industrials
WULF
TERAWULF INC. Financial Services
JGN

Jason Griffin New

Director
Rochester, NY

Track Institutional and Insider Activities on ATNF

Follow 180 Life Sciences Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATNF shares.

Notify only if

Insider Trading

Get notified when an 180 Life Sciences Corp. insider buys or sells ATNF shares.

Notify only if

News

Receive news related to 180 Life Sciences Corp.

Track Activities on ATNF